Miltefosine for Brazilian Visceral Leishmaniasis

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

April 30, 2007

Study Completion Date

October 31, 2007

Conditions
Kala Azar
Interventions
DRUG

Miltefosine: initially 2.5 mg/kg/day for 28 days

Trial Locations (1)

Unknown

Universidade Estadual de Montes Claros, Montes Claros

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

AEterna Zentaris

INDUSTRY

lead

AB Foundation

OTHER